Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines

Despite the recent development of immunotherapies that target programmed death-1 (PD-1) or programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC) treatment, these therapies are less effective in NSCLC patients with epidermal growth factor receptor (EGFR) mutations. However, the mole...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomed Res Int
Главные авторы: Suda, Kenichi, Rozeboom, Leslie, Furugaki, Koh, Yu, Hui, Melnick, Mary Ann C., Ellison, Kim, Rivard, Christopher J., Politi, Katerina, Mitsudomi, Tetsuya, Hirsch, Fred R.
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651099/
https://ncbi.nlm.nih.gov/pubmed/29119113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7694202
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы